Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Open Access
- 1 July 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 135 (1) , 192-199
- https://doi.org/10.4049/jimmunol.135.1.192
Abstract
Anti-mu antibody preparations have been found to exert both positive and negative effects on B cell activation and differentiation. To explore these paradoxical influences of IgM cross-linkage on human B cells, three gamma 1 kappa murine monoclonal antibodies specific for human mu-chains (DA4.4, AB6.4, 145.8) were examined for their comparative effects on activation of B cells and inhibition of terminal plasma cell differentiation. All three antibodies appeared equally efficient in immunoprecipitation of surface IgM molecules; however, fluorescence-activated cell sorter analysis revealed that the DA4.4 and AB6.4 antibodies saturated the B cell surface IgM at slightly lower concentrations than did the 145.8 antibody. When the affinity-purified antibodies were added in varying concentrations to cultures of small resting B cells, all three antibodies induced B cell enlargement and DNA synthesis, but with varying degrees of efficiency (DA4.4 greater than AB6.4 much greater than 145.8). In striking contrast, large B cells isolated either by FACS or density gradient separation were unresponsive. The anti-mu-induced proliferative response of small B cells required relatively high B cell densities, but not T cells or the Fc portion of the antibody molecules. The maximal proliferative response was obtained during the third day of culture, and the response curve suggested that anti-mu induced only one round of B cell replication. All three antibodies were capable of completely inhibiting T cell factor-induced differentiation of large B cells into IgM plasma cells; both F(ab')2 fragments and intact anti-mu antibodies were effective in final concentrations as low as 1 microgram/ml. Significant suppression of IgG and IgA plasma cell differentiation was also achieved, but required higher concentrations of the anti-mu antibodies. For each antibody, there was a close correlation between the efficiency of inducing small B cell proliferation and of inhibiting large B cell differentiation into plasma cells. The results show that the B cell response to cross-linkage of cell surface IgM varies according to the differentiation stage. We postulate that the mature resting B cell represents the only stage in the life history of the B cell during which surface Ig cross-linkage leads to a positive signal, negative signals being the rule at other stages in B cell replication and differentiation.This publication has 36 references indexed in Scilit:
- Stimulation of murine B cells with anti‐Ig antibodies: dominance of a negative signal mediated by the Fc receptorEuropean Journal of Immunology, 1980
- Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion.The Journal of Experimental Medicine, 1980
- Structural studies of murine lymphocyte surface IgD.The Journal of Immunology, 1980
- Stimulation of human B lymphocytes by antibodies to IgM and IgG: Functional evidence for the expression of IgG on B-lymphocyte surface membranesClinical Immunology and Immunopathology, 1980
- A New Mouse Myeloma Cell Line that Has Lost Immunoglobulin Expression but Permits the Construction of Antibody-Secreting Hybrid Cell LinesThe Journal of Immunology, 1979
- B Lymphocyte: Activation by Insoluble Anti-Immunoglobulin: Induction of Immunoglobulin Secretion by a T Cell-Dependent Soluble FactorThe Journal of Immunology, 1979
- Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors.The Journal of Experimental Medicine, 1979
- ANTI-IMMUNOGLOBULIN STIMULATION OF MURINE LYMPHOCYTES .2. IDENTIFICATION OF CELL-SURFACE TARGET MOLECULES AND REQUIREMENTS FOR CROSS-LINKAGE1976
- STUDIES ON RABBIT LYMPHOCYTES IN VITROThe Journal of Experimental Medicine, 1965
- Induction of immunological paralysis in two zones of dosageProceedings of the Royal Society of London. B. Biological Sciences, 1964